NeuroVive Pharmaceutical AB Год IPO
Что обозначает Год IPO в NeuroVive Pharmaceutical AB?
Год IPO NeuroVive Pharmaceutical AB является 2018
Какое определение для Год IPO?
Первичное публичное размещение акций - это тип публичного предложения, при котором акции компании обычно продаются институциональным инвесторам, которые, в свою очередь, впервые продают эти акции широкой публике на фондовой бирже.
Through IPO a privately held company transforms into a public company. Initial public offerings are mostly used by companies to raise the expansion of capital, possibly to monetize the investments of early private investors, and to become publicly traded enterprises. A company selling shares is never required to repay the capital to its public investors. After the IPO, when shares trade freely in the open market, money passes between public investors.
Although IPO offers many advantages, there are also significant disadvantages, chief among these are the costs associated with the process and the requirement to disclose certain information that could prove helpful to competitors.
The IPO process is colloquially known as going public. Details of the proposed offering are disclosed to potential purchasers in the form of a lengthy document known as a prospectus. Most companies undertake an IPO with the assistance of an investment banking firm acting in the capacity of an underwriter. Underwriters provide several services, including help with correctly assessing the value of shares.
Год IPO компаний в Health Care сектор на OTC по сравнению с NeuroVive Pharmaceutical AB
Что делает NeuroVive Pharmaceutical AB?
Abliva AB (publ), a pharmaceutical company, engages in the research and development of mitochondrial medicine. The company is developing KL1333 that is in Phase I clinical trials for the chronic treatment of primary mitochondrial diseases; NV354, which is in the preparation for clinical trials for the treatment of primary mitochondrial diseases with Complex I deficiency; and NeuroSTAT for traumatic brain injury. It has collaboration agreements with Isomerase, Yungjin Pharm, University of Pennsylvania, Children's Hospital of Philadelphia, Patheon, and Oroboros Instruments. The company was formerly known as NeuroVive Pharmaceutical AB (publ) and changed its name to Abliva AB (publ) in May 2020. Abliva AB (publ) was incorporated in 2000 and is headquartered in Lund, Sweden.
Компании с год ipo похож на NeuroVive Pharmaceutical AB
- Mediawan SA имеет Год IPO из 2017
- Southern имеет Год IPO из 2017
- Polytec Hldg Ag Inh. Eo 1 имеет Год IPO из 2017
- Roots Sustainable Agricultural Technologies имеет Год IPO из 2017
- Galena Mining имеет Год IPO из 2017
- MVC Capital Inc имеет Год IPO из 2017
- NeuroVive Pharmaceutical AB имеет Год IPO из 2018
- Bermele plc имеет Год IPO из 2019
- Twin River Worldwide имеет Год IPO из 2019
- Contel Technology имеет Год IPO из 2019
- GraniteShares 3x Long Diageo Daily ETC имеет Год IPO из 2019
- Pinterest Inc имеет Год IPO из 2019
- Ferrellgas Partners, L.P имеет Год IPO из 2019